Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Moodys
McKinsey
Dow
Express Scripts

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Litigation Details for Genzyme Corporation v. Impax Laboratories, Inc. (D. Maryland 2009)

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Genzyme Corporation v. Impax Laboratories, Inc. (D. Maryland 2009)

Docket   Start Trial Date Filed 2009-04-03
Court District Court, D. Maryland Date Terminated 2012-09-10
Cause 35:271 Patent Infringement Assigned To J. Frederick Motz
Jury Demand Defendant Referred To
Parties GENZYME CORPORATION; IMPAX LABORATORIES, INC.
Patents 5,667,775; 6,733,780
Attorneys Adam S Nadelhaft; Brian D O Reilly; Cathleen Joy Phillips; Charlotte Jacobsen; Christopher Earl Loh; Donald J Curry; Filko Prugo; Geoffrey H Genth; George E Brown; James Francis Hurst; Jared L Stringham; Jason E O Leary; Kevin Warner; Lindsay M Beyer; Maureen Rurka; Michael A Del Negro; Robert L Baechtold; Scott K Reed; Susanne Flanders; Susanne L Flanders
Link to Docket External link to docket
Small Molecule Drugs cited in Genzyme Corporation v. Impax Laboratories, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for Genzyme Corporation v. Impax Laboratories, Inc. (D. Maryland 2009)

Date Filed Document No. Description Snippet Link To Document
2009-08-21 26 paragraph 20. 21. Genzyme lists U.S. Patent Nos. 5,667,775 (“the ‘775 patent”), among others, in the Orange …Genzyme lists the ‘775 patent and the ‘780 patent in the Orange Book. Thus, the ‘775 patent is listed in connection… 2.- U.S. Patent No. 6.733.780 3. On information and belief, on May ll, 2004, U.S. Patent No. 6,733,780…of 18 the ‘780 patent lists Genzyme Corporation as assignee A copy of the ‘780 patent is attached hereto…has the right under the Patent Act to sue for infringement of the ‘780 patent. ANSWER: Genzyme admits External link to document
2009-08-21 27 paragraph 20. 21. Genzyme lists U.S. Patent Nos. 5,667,775 (“the ‘775 patent”), among others, in the Orange …Genzyme lists the ‘775 patent and the ‘780 patent in the Orange Book. Thus, the ‘775 patent is listed in connection… 2.- U.S. Patent No. 6.733.780 3. On information and belief, on May ll, 2004, U.S. Patent No. 6,733,780…of 18 the ‘780 patent lists Genzyme Corporation as assignee A copy of the ‘780 patent is attached hereto…has the right under the Patent Act to sue for infringement of the ‘780 patent. ANSWER: Genzyme admits External link to document
2009-08-21 28 Text of Proposed Order Infringement and Invalidity of United States Patent No. 6,733,780 by Genzyme Corporation Responses due by … 10 September 2012 1:09-cv-00846 830 Patent Defendant District Court, D. External link to document
2009-08-28 30 Infringement and Invalidity of United States Patent No. 6,733,780 by Impax Laboratories, Inc. Responses due… 10 September 2012 1:09-cv-00846 830 Patent Defendant District Court, D. External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Johnson and Johnson
Merck
Boehringer Ingelheim
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.